| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/23/2004 | EP1036075B1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties |
| 06/23/2004 | EP1024801B1 Method for regulating size and growth of vascularized normal tissue |
| 06/23/2004 | EP1003500A4 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
| 06/23/2004 | EP0999839B1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 06/23/2004 | EP0966424B1 Aminobenzophenones as inhibitors of interleukin and tnf |
| 06/23/2004 | EP0779889B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/23/2004 | CN1507450A Novel cyclo azaphospha hydrocarbons |
| 06/23/2004 | CN1507447A Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 06/23/2004 | CN1507442A Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1507435A Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 06/23/2004 | CN1507352A Compound plant medicine and its application |
| 06/23/2004 | CN1507348A Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
| 06/23/2004 | CN1507345A Method to prepare microparticles metoprolol that contain |
| 06/23/2004 | CN1506459A Lumbricus kinase of electrophoretical purity and its prepn and use |
| 06/23/2004 | CN1506373A Composition, extraction process and use of total triterpene sapogenin extracted from bamboo |
| 06/23/2004 | CN1506360A Method of extracting effective components in kudzu vine root |
| 06/23/2004 | CN1506359A Coumarin amide derivative and its prepn, medicinal composition and use |
| 06/23/2004 | CN1506104A Three-ingredient sandalwood guttate pill and its prepn and use |
| 06/23/2004 | CN1506097A Chinese medicine capsule for treating ischemic cerebral apoplexy |
| 06/23/2004 | CN1506058A Cell growth regulating factor O and its prepn process |
| 06/23/2004 | CN1506054A Cell growth regulating factor U and its prepn process |
| 06/23/2004 | CN1506050A Prepn process of Xuesaitong guttate pills |
| 06/23/2004 | CN1506033A Depressing and antilipemic head wash |
| 06/23/2004 | CN1506032A Depressing and pain-relieving head wash |
| 06/23/2004 | CN1154654C Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl-L-proline |
| 06/23/2004 | CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same |
| 06/23/2004 | CN1154507C Inhibition of binding of Hox and homeodomain containing proteins and uses thereof |
| 06/23/2004 | CN1154494C Adenosine A3 receptor modulators |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753346 CETP activity inhibitor |
| 06/22/2004 | US6753338 Also useful for treatment of angina, as a calcium channel antagonist such as cerebral ischemia, cerebral disorders, arrhythmias, without concomitant liability of adverse effects associated with racemic mixture of amlodipine |
| 06/22/2004 | US6753336 Melanin concentrating hormone receptor ligands |
| 06/22/2004 | US6753335 Delta agonists for nervous system pain |
| 06/22/2004 | US6753334 Preparing a phenyl or quinolinyl hydrazine by reducing the corresponding diazonium salt with ascorbic acid and heating; colorless product; intermediates to drugs for reducing tissue damage from ischemia or hypoxia |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/22/2004 | US6753331 Heterocyclic derivatives which inhibit factor Xa |
| 06/22/2004 | US6753330 2-benzyl-5-(4-chlorophenyl)-6-(4-(methylthio)phenyl)-2h -pyridazin-3-one, hydroxypropylmethylcellulose, and ethylene oxide-propylene oxide copolymer; interleukin inhibitors; rheumatic diseases |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | US6753325 Comprises vitamin d3 for controlling cell differentiation and/or cell proliferation |
| 06/22/2004 | US6753321 Method of modulating neovascularization |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | CA2093502C Hydrazoadenosines |
| 06/17/2004 | WO2004050894A2 Heart failure gene determination and therapeutic screening |
| 06/17/2004 | WO2004050690A1 NOVEL χ-CONOTOXIN PEPTIDES (-I) |
| 06/17/2004 | WO2004050688A1 NOVEL χ-CONOTOXIN PEPTIDES (-II) |
| 06/17/2004 | WO2004050657A2 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050639A2 5-nitroso-6-piperazinyl-pyrimidine derivatives for treating ischemia |
| 06/17/2004 | WO2004050631A1 Substituted dihydrophenanthridinesul fonamides |
| 06/17/2004 | WO2004050126A2 Compositions for treating or preventing angiogenesis-dependent symptoms |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050113A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 06/17/2004 | WO2004050107A1 A drop pill of treating and preventing from cardio-cerebral diseases and the process of producing thereof |
| 06/17/2004 | WO2004050105A1 An anti-arrhythmic compound from king cobra venom and a process of purification thereof |
| 06/17/2004 | WO2004050088A1 Jnk inhibitor |
| 06/17/2004 | WO2004050086A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 06/17/2004 | WO2004050084A2 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 06/17/2004 | WO2004050082A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use |
| 06/17/2004 | WO2004050075A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050074A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 06/17/2004 | WO2004050013A2 Material compositions and related systems and methods for treating cardiac conditions |
| 06/17/2004 | WO2004029089A3 Novel angiogenesis target and uses thereof |
| 06/17/2004 | WO2004012651A3 Composition for heart disease, method to prepare same and uses thereof |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003105781A3 Ophthalmic compositions for treating ocular hypertension |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003070184A3 Sodium channel blockers |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003051380A3 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders |
| 06/17/2004 | WO2003039341A3 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804 |
| 06/17/2004 | WO2003037308A8 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 06/17/2004 | WO2003017992A3 Means for treatment of atherosclerosis |
| 06/17/2004 | US20040117006 Drug delivery from stents |
| 06/17/2004 | US20040116738 Conjugated unsaturated glyceride mixtures and a method for producing the same |
| 06/17/2004 | US20040116715 Tocotrienolquinone cyclisation product with an anti-hypercholesterol effect |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116698 6-Substituted pyrido-pyrimidines |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116695 2-Mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 06/17/2004 | US20040116516 Pharmaceutical composition |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116498 Regulations of lipids and/or bone density and compositions therefor |
| 06/17/2004 | US20040116497 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 06/17/2004 | US20040116495 Compounds and methods |
| 06/17/2004 | US20040116486 Metalloproteinase inhibitors |
| 06/17/2004 | US20040116483 Glucagon antagonists/inverse agonists |
| 06/17/2004 | US20040116482 Potassium channel opener |
| 06/17/2004 | US20040116478 Novel amlodipine camsylate and method for preparing thereof |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116463 excellent in stability than amorphous one and are more preferable for treatment of hyperlipidemia and atherosclerosis |
| 06/17/2004 | US20040116458 Chemical compounds |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116445 Substituted thioacetamides |
| 06/17/2004 | US20040116440 Useful for diagnosis, treatment of male or female sexual dysfunction |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116438 Compositions for treatment of cell proliferation disorders |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |